PYRAZINE KINASE INHIBITORS
PANDEY ANJALI, SONG YONGHONG, XU QING, JIA ZHAOZHONG J, KANE BRIAN, BAUER SHAWN M
Year of Publication 25.07.2014
Get full text
Year of Publication 25.07.2014
Patent
2,6-DIAMINO-PYRIMIDIN-5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS
ROSE JACK W, PANDEY ANJALI, HUANG WOLIN, MEHROTRA MUKUND, JIA ZHAOZHONG J, SONG YONGHONG, XU QING, KANE BRIAN, BAUER SHAWN M, VENKATARAMANI CHANDRASEKAR
Year of Publication 25.07.2016
Get full text
Year of Publication 25.07.2016
Patent
Abbv-101, a Highly Potent and Selective Clinical Stage Bruton Tyrosine Kinase Degrader for the Treatment of B-Cell Malignancies
Pan, Chin, Gururaja, Tarikere L, Li, Haiyan, Nguyen, Henry, Zhai, Yongjiao, Xie, Xiaoping, Ding, Rong-Xian, Mathew, Rebecca, Hoh, Hana Y, Jia, Zhaozhong J, Liu, Bo, Shu, Cassandra, Assaily, Wissam, Lam, Lloyd T, Riehm, Jacob J, Stevenson, Claudina, Will, Christine, Innocenti, Federico, Rivkin, Alexey
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
1-(2-Naphthyl)-1 H -pyrazole-5-carboxylamides as potent factor Xa inhibitors. Part 3: Design, synthesis and SAR of orally bioavailable benzamidine-P4 inhibitors
Jia, Zhaozhong J., Wu, Yanhong, Huang, Wenrong, Zhang, Penglie, Song, Yonghong, Woolfrey, John, Sinha, Uma, Arfsten, Ann E., Edwards, Susan T., Hutchaleelaha, Athiwat, Hollennbach, Stanley J., Lambing, Joseph L., Scarborough, Robert M., Zhu, Bing-Yan
Published in Bioorganic & medicinal chemistry letters (01.03.2004)
Published in Bioorganic & medicinal chemistry letters (01.03.2004)
Get full text
Journal Article
Design, Synthesis, and SAR of Amino Acid Derivatives as Factor Xa Inhibitors
Su, Ting, Wu, Yanhong, Doughan, Brandon, Jia, Zhaozhong J., Woolfrey, John, Huang, Brian, Wong, Paul, Park, Gary, Sinha, Uma, Scarborough, Robert M., Zhu, Bing-yan
Published in Bioorganic & medicinal chemistry letters (19.11.2001)
Published in Bioorganic & medicinal chemistry letters (19.11.2001)
Get full text
Journal Article
Abstract 605: ABBV-101, a highly potent and selective clinical stage Bruton tyrosine kinase degrader, overcomes BTK mutation-induced resistance to BTK inhibitors
Pan, Chin, Riehm, Jacob, Gururaja, Tarikere L., Li, Haiyan, Nguyen, Henry, Zhai, Yongjiao, Xie, Xiaoping, Ding, Rong-Xian, Matthew, Rebecca, Hoh, Hana Y., Jia, Zhaozhong J., Liu, Bo, Shu, Cassandra P., Stevenson, Claudina A., Will, Christine, Innocenti, Federico, Assaily, Wissam, Lam, Lloyd T., Rivkin, Alexey
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
2,6-DIAMINO-PYRIMIDIN-5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS
ROSE JACK W, PANDEY ANJALI, HUANG WOLIN, MEHROTRA MUKUND, JIA ZHAOZHONG J, SONG YONGHONG, XU QING, KANE BRIAN, BAUER SHAWN M, VENKATARAMANI CHANDRASEKAR
Year of Publication 17.12.2010
Get full text
Year of Publication 17.12.2010
Patent
2,6-DIAMINO-PYRIMIDIN-5-YL-CARBOXAMIDES AS SYK OR JAK KINASES INHIBITORS
ROSE JACK W, PANDEY ANJALI, HUANG WOLIN, MEHROTRA MUKUND, JIA ZHAOZHONG J, SONG YONGHONG, XU QING, BAUER SHAWN M, VENKATARAMANI CHANDRASEKAR
Year of Publication 02.12.2010
Get full text
Year of Publication 02.12.2010
Patent
Specific Inhibition of Syk Suppresses Leukocyte Immune Function and Alleviates Inflammation In Rodent Models of Rheumatoid Arthritis
Coffey, Greg, Francis, DeGuzman, Inagaki, Mayuko, Pak, Yvonne, Delaney, Suzanne, Betz, Andreas, Jia, Zhaozhong J, Xu, Qing, Bauer, Shawn, Song, Yonghong, Pandey, Anjali, Baker, Dale, Hollenbach, Stanley, Phillips, David R., Sinha, Uma
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article
Inhibition of Syk Activity Is Sufficient for Inhibitory Effect in Animal Models of Autoimmune Diseases
Hollenbach, Stanley J, Coffey, Greg, DeGuzman, Francis R, Inagaki, Mayuko, Pandey, Anjali, Jia, Zhaozhong J, Xu, Qing, Bauer, Shawn, Baker, Dale, Nanda, Nisha, Phillips, David R, Sinha, Uma
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article
Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido )-5-metho xybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor
Zhang, Penglie, Huang, Wenrong, Wang, Lingyan, Bao, Liang, Jia, Zhaozhong J, Bauer, Shawn M, Goldman, Erick A, Probst, Gary D, Song, Yonghong, Su, Ting, Fan, Jingmei, Wu, Yanhong, Li, Wenhao, Woolfrey, John, Sinha, Uma, Wong, Paul W, Edwards, Susan T, Arfsten, Ann E, Clizbe, Lane A, Kanter, James, Pandey, Anjali, Park, Gary, Hutchaleelaha, Athiwat, Lambing, Joseph L, Hollenbach, Stanley J, Scarborough, Robert M, Zhu, Bing-Yan
Published in Bioorganic & medicinal chemistry letters (01.04.2009)
Published in Bioorganic & medicinal chemistry letters (01.04.2009)
Get full text
Journal Article
Inhibitory effect of carboxylic acid group on hERG binding This paper is dedicated to the memory of Robert M. Scarborough, inventor of Integrilin and Natrecor
Zhu, Bing-Yan, Jia, Zhaozhong J, Zhang, Penglie, Su, Ting, Huang, Wenrong, Goldman, Erick, Tumas, Daniel, Kadambi, Vic, Eddy, Priya, Sinha, Uma, Scarborough, Robert M, Song, Yonghong
Published in Bioorganic & medicinal chemistry letters (01.11.2006)
Published in Bioorganic & medicinal chemistry letters (01.11.2006)
Get full text
Journal Article